| Investments and Other |
| | | | December 28, | | December 29, | | | | | 2013 | | 2012 | | Investment in unconsolidated affiliates | | $ | 205,556 | | $ | 191,075 | | Non-current deferred foreign, state and local income taxes | | | 48,470 | | | 37,737 | | Notes receivable (1) | | | 10,836 | | | 9,851 | | Auction rate securities, net of temporary impairment | | | 2,654 | | | 2,816 | | Distribution rights and exclusivity agreements, net of amortization | | | 3,321 | | | 4,030 | | Security deposits | | | 3,341 | | | 3,291 | | Debt issuance costs, net of amortization | | | 2,011 | | | 7,207 | | Acquisition related indemnification | | | 13,880 | | | 14,168 | | Acquisition related loan receivable (2) | | | 145,000 | | | - | | Other long-term assets | | | 26,876 | | | 22,759 | | | Total | | $ | 461,945 | | $ | 292,934 | | | | | | | | | | | | | | | | | | | | (1) | Long-term notes receivable carry interest rates ranging from 2.17% to 12.0% and are due in varying installments through | | | December 31, 2020. | | | | | | | | | | | (2) | See Note 9 - Business Acquisitions, Divestiture and Other Transaction for additional details of the loan receivable from | | | BioHorizons, Inc. |
|